Transgene has requested the suspension of its shares on Euronext Paris pending the publication of its capital increase results. Trading is set to resume on November 27, 2025. The company, known for its cancer immunotherapy products, has a portfolio of viral vector-based immunotherapies in development. Its lead candidate, TG4050, has shown promise in clinical trials for head and neck cancer. Transgene’s innovative myvac® platform allows for patient-specific immunotherapy by integrating tumor mutations. The company’s forward-looking statements highlight potential risks and uncertainties. The offering of Transgene shares in France involves a capital increase and a public offering on the PrimaryBid platform, while in the European Economic Area, no public offering has been initiated. The press release is intended for specific categories of investors in the United Kingdom. Transgene suspends trading in the United States due to restrictions under the U.S. Securities Act. The company’s securities are not registered under the Act and will not be offered to the public in the U.S. MiFID II guidelines determine the target market for Transgene shares as eligible counterparties and professional clients. It is the distributor’s responsibility to assess the target market and choose appropriate distribution channels. Legal and regulatory restrictions may apply to the distribution of this press release in certain jurisdictions. Any decision to purchase Transgene securities should be based on publicly available information.

Read more at 1. “Tech giant Apple announces plans to launch new subscription service for podcasts.” – CNBC

2. “Tesla reports record-breaking profits in the second quarter, doubling their earnings from the previous year.” – Reuters

3. “Amazon Prime Day sales surpass $10 billion, setting a new record for the online retail giant.” – Wall Street Journal

4. “Facebook unveils new virtual reality headset, promising an immersive gaming experience for users.” – CBS MarketWatch

5. “Google announces partnership with SpaceX to provide Starlink satellite internet service to remote areas.” – Barchart: Transgene Announces the Temporary Suspension of Trading of